The other face of facioscapulohumeral muscular dystrophy: Exploring orofacial weakness using muscle ultrasound
Authors:
- Sanne C. C. VincentenSVSanne C. C. Vincenten
- Jeroen L. M. van DoornJDJeroen L. M. van Doorn
- Sjan TeeselinkSTSjan Teeselink
- Nathaniel B. RasingNRNathaniel B. Rasing
- George W. PadbergGPGeorge W. Padberg
- Nicol C. VoermansNVNicol C. Voermans
- Baziel G. M. van EngelenBEBaziel G. M. van Engelen
- Nens van AlfenNANens van Alfen
- Karlien MulKMKarlien Mul
Open Access
- 19 September 2024
- journal article
- research article
- Published by Wiley in Muscle & Nerve
- Vol. 70 (5) , 1062-1071
Abstract
Introduction/Aims: One of the most distinct clinical features of facioscapulohumeral muscular dystrophy (FSHD) is facial weakness. It leads to diminished facial expression and functional impairments. Despite its clinical relevance, little else is known about orofacial muscle involvement. We therefore evaluated orofacial muscle involvement in a sizeable cohort of FSHD participants with muscle ultrasound. Methods: Muscle ultrasound images of the following orofacial muscles were scored visually and quantitatively: depressor anguli oris (DAO), orbicularis oris (OO), buccinator, temporalis, masseter, digastric, zygomaticus major and minor bilaterally, and the geniohyoid. Reliability analyses of both visual and quantitative evaluations were performed. Ultrasound results were correlated with other measures: the FSHD clinical score, facial weakness score, and facial function scale. Results: We included 107 FSHD participants (male 54%; age 52 ± 14 years), of whom 92% showed signs of facial weakness. The reliability of visual ultrasound analysis varied widely (κ 0.0–1.0). Quantitative ultrasound reliability was high (intraclass correlation analysis ≥ 0.96). The DAO, buccinator, OO, temporalis, and zygomaticus minor muscles were affected most often (15%–39%). The digastric, geniohyoid, zygomaticus major, and masseter muscles were least often affected (ρ = 0.3–0.7). Discussion: This study adds to the understanding of orofacial weakness in FSHD, confirming the involvement of the muscles of facial expression in FSHD using ultrasound. We showed that orofacial muscle ultrasound is feasible and reliable when quantitatively assessed. Future studies should evaluate orofacial muscle ultrasound longitudinally, alongside clinical and patient‐reported facial weakness outcome measures, to assess their potential as outcome measures.Keywords
Funding Information
- Prinses Beatrix Spierfonds (W.OR12‐22)
- Prinses Beatrix Spierfonds (W.OR18‐07)
This publication has 37 references indexed in Scilit:
- Face to Face: deciphering facial involvement in inclusion body myositisJournal of Neurology, 2023
- Validity and reliability of visual assessment of orofacial muscle ultrasound images using a modified Heckmatt scaleMuscle & Nerve, 2023
- Muscle ultrasound: Present state and future opportunitiesMuscle & Nerve, 2020
- Quantitative muscle MRI and ultrasound for facioscapulohumeral muscular dystrophy: complementary imaging biomarkersJournal of Neurology, 2018
- Magnetic resonance imaging in a large cohort of facioscapulohumeral muscular dystrophy patients: Pattern refinement and implications for clinical trialsAnnals of Neurology, 2016
- Quantitative muscle ultrasound versus quantitative magnetic resonance imaging in facioscapulohumeral dystrophyMuscle & Nerve, 2014
- Minimal training is required to reliably perform quantitative ultrasound of muscleMuscle & Nerve, 2013
- Quantitative facial muscle ultrasound: Feasibility and reproducibilityMuscle & Nerve, 2013
- Quantitative ultrasonography of facial musclesMuscle & Nerve, 2012
- A standardized clinical evaluation of patients affected by facioscapulohumeral muscular dystrophy: The FSHD clinical scoreMuscle & Nerve, 2010